Linyang Chu
Impact in
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
- Biomedical Engineering top 10%
- Bone Tissue Engineering Materials
- Graphene and Nanomaterials Applications
- 3D Printing in Biomedical Research
- Nanoplatforms for cancer theranostics
Papers in
-
- Bone Tissue Engineering Materials 6
- Lower Extremity Biomechanics and Pathologies 2
- Surgery 8
- Orthopaedic implants and arthroplasty 4
- Orthopedic Infections and Treatments 2
- Co-authors
- Tingting Tang (9 shared papers)Shengbing Yang (3 shared papers)Minqi Wang (3 shared papers)Feng Zhou (3 shared papers)Hanjun Li (1 shared paper)Han Qiao (1 shared paper)Jingtian Mei (1 shared paper)Xiuguo Han (2 shared papers)
- Journals
- Journal of Orthopaedic Translation (3 papers)Osteoarthritis and Cartilage (2 papers)Journal of Materials Chemistry B (2 papers)ACS Biomaterials Science & Engineering (2 papers)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited KingdomSweden
In The Last Decade
Linyang Chu
20 papers receiving 954 citations
Linyang Chu's Hit Papers
Peers
Comparison fields: 5 of 89
- Rheumatology 221
- Biomedical Engineering 338
- Biomaterials 87
- Orthodontics 25
- Oral Surgery 39
Countries citing papers authored by Linyang Chu
This map shows the geographic impact of Linyang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linyang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linyang Chu more than expected).
Fields of papers citing papers by Linyang Chu
This network shows the impact of papers produced by Linyang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linyang Chu. The network helps show where Linyang Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Linyang Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-κB/MAPK signaling and protecting chondrocytes Hit paper breakdown → | 2019 | 305 |
| 2 | 2018 | 181 | |
| 3 | 2019 | 66 | |
| 4 | 2019 | 57 | |
| 5 | 2016 | 53 | |
| 6 | 2020 | 37 | |
| 7 | 2018 | 33 | |
| 8 | 2019 | 33 | |
| 9 | 2015 | 31 | |
| 10 | 2020 | 30 | |
| 11 | 2018 | 30 | |
| 12 | 2021 | 22 | |
| 13 | 2019 | 20 | |
| 14 | 2018 | 18 | |
| 15 | 2019 | 16 | |
| 16 | 2019 | 15 | |
| 17 | 2021 | 10 | |
| 18 | 2025 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2019 | 1 |
About Linyang Chu
Linyang Chu is a scholar working on Biomedical Engineering, Surgery, Rheumatology, Molecular Biology and Biomaterials, having authored 20 papers that have together received 960 indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (6 papers), Osteoarthritis Treatment and Mechanisms (5 papers), Orthopaedic implants and arthroplasty (4 papers), Lower Extremity Biomechanics and Pathologies (2 papers), Orthopedic Infections and Treatments (2 papers), Cerebrospinal fluid and hydrocephalus (1 paper), Bone and Joint Diseases (1 paper) and Electrospun Nanofibers in Biomedical Applications (1 paper). The work is most often cited by research in Rheumatology (221 citations), Biomedical Engineering (338 citations), Biomaterials (87 citations), Orthodontics (25 citations) and Oral Surgery (39 citations). Linyang Chu has collaborated with scholars based in China, United Kingdom and Sweden. Frequent co-authors include Tingting Tang, Shengbing Yang, Minqi Wang, Feng Zhou, Hanjun Li, Han Qiao, Jingtian Mei, Xiuguo Han, Ying Yang and Zhifeng Yu. Their work appears in journals such as Journal of Orthopaedic Translation, Osteoarthritis and Cartilage, Journal of Materials Chemistry B, ACS Biomaterials Science & Engineering and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.